News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection inColombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Statements 12 Jun 2023 DNDi initial comments on WHO CA+ Bureau Draft for consideration at the INB June Drafting Group meeting
Statements 28 Feb 2023 DNDi’s submission to the Technical Assessment component of the first Global Stocktake
Statements 22 Feb 2023 DNDi comments on the zero draft of the WHO CA+ for consideration of the Intergovernmental Negotiating Body at INB4 & 5
Statements 2 Dec 2022 DNDi‘s comments on the conceptual zero draft for the consideration of the Intergovernmental Negotiating Body at INB3
Statements 29 Sep 2022 DNDi intervention at the Intergovernmental Negotiating Body second round of public hearings
Statements 18 Jul 2022 DNDi‘s comments on the working draft of the WHO CAll for the consideration of the INB at its second meeting
Statements 23 Jun 2022 DNDi Executive Director Dr Bernard Pécoul’s address to the Kigali Summit on Malaria and NTDs
Statements 15 Jun 2022 DNDi endorses consensus statement on gender-responsive international instrument for pandemic prevention, preparedness, and response
Statements 18 Apr 2022 DNDi‘s initial comments on the Intergovernmental Negotiating Body deliberations
Statements 12 Apr 2022 DNDi intervention at the Intergovernmental Negotiating Body first round of public hearings
